Detail page

Knowledge Web

Person

Paul La Rosée (1969-)

Internist

Name	Paul La Rosée
Time	1969- (Date of birth and death)
Place	Jena (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Prof. Dr. med.
Profession	Internist (characteristic profession) Onkologe Arzt
Variant	Paul la Rosée Paul Basselet de La Rosée Paul Basselet de la Rosée P. La Rosée Paul Basselet de la Rosée Paul LaRosée (RAK alt) Paul Basselet de LaRosée (RAK alt)
Related	Universitätsklinikum Jena Klinik für Innere Medizin II (Jena)
Further information	Stand: 15.06.2015; Diss. Medizinische Fakultät; Arzt Stand: 17.03.2022
Record type	Person
GND-Identifier	122116674
Record ID	122116674
Involved in show all Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia Addendum to the German consensus recommendations on ponatinib in the treatment of chronic myeloid leukemia Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma Klinische und molekulargenetische Charakterisierung der Hämophagozytischen Lymphohistiozytose des Erwachsenen : eine Nationale Registerstudie Case report: Hemophagocytic lymphohistiocytosis and non-tuberculous mycobacteriosis caused by a novel GATA2 variant Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma Präklinische Charakterisierung von Pacritinib bei chronischer myeloischer Leukämie Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German Expert Consensus Panel with focus on cardiovascular management Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German expert consensus panel with focus on cardiovascular management Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management Consensus statement for cancer patients requiring intensive care support Mutationsanalyse des Tumorsuppressorgens TNFAIP 3 im klassischen Hodgkin-Lymphom Therapie der chronischen myeloischen Leukämie nach Versagen der Erstlinientherapie Die kardiale Proteinkinase C in der postnatalen Entwicklung und der chronischen myokardialen Hypertrophie der Ratte

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Paul La Rosée (1969-)

Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis

Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia

Addendum to the German consensus recommendations on ponatinib in the treatment of chronic myeloid leukemia

Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma

Klinische und molekulargenetische Charakterisierung der Hämophagozytischen Lymphohistiozytose des Erwachsenen : eine Nationale Registerstudie

Case report: Hemophagocytic lymphohistiocytosis and non-tuberculous mycobacteriosis caused by a novel GATA2 variant

Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma

Präklinische Charakterisierung von Pacritinib bei chronischer myeloischer Leukämie

Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry

Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry

Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German Expert Consensus Panel with focus on cardiovascular management

Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German expert consensus panel with focus on cardiovascular management

Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management

Consensus statement for cancer patients requiring intensive care support

Mutationsanalyse des Tumorsuppressorgens TNFAIP 3 im klassischen Hodgkin-Lymphom

Therapie der chronischen myeloischen Leukämie nach Versagen der Erstlinientherapie

Die kardiale Proteinkinase C in der postnatalen Entwicklung und der chronischen myokardialen Hypertrophie der Ratte